Generate a baseline inspection screen for braided, coiled, and hybrid reinforced catheter shafts, then use the evidence guide below to turn that screen into device-specific CTQs, DVP&R tests, and lot-release controls.
Select the shaft architecture, jacket material, and coating state to produce a baseline inspection screen with risk level, required methods, acceptance-basis notes, and next-step engineering inputs.
Torque response, pushability, braid angle, and ovalization.
Balanced flexibility and reflow behavior for many shaft zones.
Adds friction, durability, and particulate evidence requirements.
The generated protocol will list inspection methods, acceptance basis, likely failure modes, assumptions, and the minimum data needed for an engineering RFQ.
The tool above gives a starting screen. The report layer below explains how to connect that screen to traceable evidence, acceptance boundaries, and supplier-ready next steps.
Evidence: FDA recognition records and ISO catalog pages establish the general intravascular catheter and risk-management framework, but they do not publish universal braid PPI, coil pitch, hybrid overlap, or birdcaging thresholds.
Action: Use recognized standards as the evidence frame, then define device-specific CTQs in drawings, the risk file, DVP&R, and the lot control plan.
Evidence: Braid-to-coil sections concentrate stiffness changes, reinforcement terminations, polymer wet-out risk, and localized bend load in a short shaft length.
Action: Inspect the transition separately with microscopy, zone-by-zone dimensions, and localized bend-to-failure evidence instead of averaging results across the whole shaft.
Evidence: FDA coating guidance points engineering teams toward simulated-use, particulate, and coating-durability evidence for lubricious-coated intravascular devices.
Action: Run coating-related inspection on the finished configuration, including final bonding, handling, and sterilization state where applicable.
Evidence: QMSR and 21 CFR Part 820 place emphasis on design controls, production controls, acceptance activities, validation, and documented records.
Action: Capture fixture settings, sample rationale, measured values, nonconformance triggers, and lot-release decision rules with every inspection plan.
| Parameter | Braid Dominant | Coil Dominant | Hybrid Construction |
|---|---|---|---|
| Primary inspection focus | Torque response, braid angle, ovalization, wet-out around wire | Kink radius, coil pitch, wire gap stability, axial elongation | Transition continuity, overlap length, delamination, stiffness shift |
| Most useful dimensional evidence | Picks per inch, braid angle trend, OD/ID after bend fixture | Pitch map, gap uniformity, OD/ID through bend and pull tests | Zone map, transition OD continuity, cross-section measurements |
| Functional screen | Torque response and bend ovalization | Kink resistance and tensile elongation | Localized bend-to-failure and transition tensile challenge |
| Common false confidence | Good appearance hiding incomplete polymer wet-out | Uniform pitch before handling but drift after simulated use | Passing whole-shaft bend tests while the transition dominates risk |
| Evidence owner | Drawing CTQs plus process capability records | Pitch fixture records plus functional test history | Risk file, DVP&R, cross-section images, and transition-zone data |
A useful catheter shaft protocol should name the risk, select the test method, define the acceptance basis, and preserve the record needed for design transfer or lot release.
Separate proximal braid, transition overlap, distal coil, marker bands, coating, and bonded joints before choosing tests.
Every inspection should answer a named risk: lumen collapse, wire movement, delamination, coating lift, or tensile failure.
Use drawings, risk controls, DVP&R limits, and lot-release rules before arguing about AQL or sample quantity.
Keep images, fixture settings, sample IDs, measured values, and disposition decisions with the manufacturing record.
| Failure Mode | Inspection Method | Evidence to Keep | Escalation Trigger |
|---|---|---|---|
| Dimensional drift or lumen loss | OD/ID, wall thickness, zone length, and lumen patency measurement | First-article report, lot record, calibrated fixture ID | Hold the lot when drift clusters by mandrel, reflow recipe, or zone. |
| Braid birdcaging or poor wet-out | 360-degree visual inspection, braid angle map, bend fixture, cross-section microscopy | Image record with zone location, bend radius, and operator or vision-system review | Escalate visible wire separation, voids, exposed wire, or post-bend expansion. |
| Coil pitch shift or elongation | Pitch map before and after simulated bending, tensile elongation test | Pre/post pitch trend, tensile load curve, sample traceability | Escalate uncontrolled wire movement, lumen collapse, or jacket split. |
| Hybrid transition delamination | Localized bend-to-failure, transition cross-section, overlap measurement | Transition-zone images, measured overlap, failure-location notes | Treat transition-zone failure as a design review item, not a cosmetic defect. |
| Coating lift or particulate generation | Simulated-use track, particulate screen, friction or lubricity trend | Finished coated and sterilized configuration, fluid path, pass count, particle count | Retest after process changes affecting coating, bonding, cleaning, or packaging. |
| Weak lot-release control | Sampling plan review, Gage R&R or fixture validation, nonconformance triggers | Control plan, inspection work instruction, validation report, lot disposition record | Do not release based on undocumented visual judgement for CTQ or safety-linked defects. |
Known evidence: Target OD, ID, wall, length, marker, and reinforcement zones can be measured directly.
Boundary: Tolerance bands must come from the controlled drawing, not a generic catheter page.
Known evidence: PPI, braid angle, coil pitch, wire gap, and overlap can be trended with fixtures or image systems.
Boundary: Universal public limits do not exist for every architecture; set limits from function and risk.
Known evidence: Cross-sections and localized bend tests expose wet-out gaps, delamination, and stiffness discontinuity.
Boundary: Whole-shaft averages can hide transition failure; transition samples need separate disposition logic.
Known evidence: Simulated-use, friction, and particulate screens can be run on finished coated devices.
Boundary: Uncoated or pre-sterilization evidence may be useful development data but is not a substitute for final-state testing.
Known evidence: Sampling can be tied to validation history, CTQ severity, and process capability.
Boundary: AQL alone is weak when the defect is safety-linked or only visible after destructive testing.
Recognition record checked July 29, 2026
Use: Confirms U.S. recognition context for the general intravascular catheter standard.
Limit: Does not provide universal braid pick-count, coil pitch, hybrid overlap, or birdcaging acceptance limits.
Third edition catalog page checked July 29, 2026
Use: Frames general requirements for sterile single-use intravascular catheters.
Limit: Program-specific inspection methods still need drawings, risk controls, and DVP&R criteria.
Guidance page checked July 29, 2026
Use: Supports simulated-use, particulate, durability, and labeling considerations for coated intravascular devices.
Limit: Coating guidance does not replace structural shaft verification for braid, coil, or hybrid reinforcement.
QMSR page checked July 29, 2026
Use: Establishes the quality-system context for design controls, production controls, and records.
Limit: Quality-system rules define evidence expectations, not catheter-specific numerical shaft limits.
eCFR page checked July 29, 2026
Use: Provides traceable regulatory text for design, process, acceptance, and validation records.
Limit: Use alongside current FDA transition guidance and program-specific quality plans.
Catalog page checked July 29, 2026
Use: Frames risk-management reasoning for hazards such as delamination, particulate, and transition failure.
Limit: The risk file must translate hazards into measurable catheter-shaft controls.
Inspection should not force the design toward one isolated metric. Reinforcement density, jacket flow, coating performance, and transition geometry all trade against each other.
Transition-zone defects can be invisible in global pass/fail tests. Isolate the zone and preserve images with location data.
Mitigate with controlled reflow, cross-section sampling, and torque-response evidence by shaft zone.
Balance pitch uniformity with bend-path performance and axial elongation testing.
Use transition microscopy and OD continuity checks to prove the overlap is doing useful work.
Test friction, durability, and particulate on the final coated configuration, not only on development samples.
Use these scenarios to check whether the generated protocol is emphasizing the right risk for the intended clinical route and manufacturing stage.
Watch: Small OD, tight bend path, and coated distal segment increase sensitivity to kink, coating lift, and lumen loss.
Action: Prioritize final-state simulated-use, kink radius, particulate, and post-bend lumen measurement.
Watch: Dense braid may improve torque but can create jacket wet-out and delamination risk during reflow.
Action: Pair torque-response data with cross-section microscopy and braid angle mapping by shaft zone.
Watch: A prototype can pass global bending while the braid-to-coil overlap remains the first failure point.
Action: Add transition-only bend-to-failure, overlap measurement, and separate lot disposition rules.
Move between inspection planning, DFM checks, architecture selection, and supplier qualification without changing the page goal.
Move from inspection planning into manufacturability risks, wall budget, and scale-up controls.
Compare architecture choices before finalizing the inspection protocol.
Evaluate supplier evidence, transfer controls, and production readiness.
Use a broader outsourcing view when inspection planning needs supplier qualification.
Send the shaft architecture, target dimensions, reinforcement zones, coating state, simulated-use path, and known CTQs. Our engineering team can review manufacturability, inspection methods, and quote assumptions together.